Kyntra Bio

Contributing Author

Recent Articles by Kyntra Bio

4 hours	Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update KYNB GlobeNewswire
Mar-09	Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results KYNB +7.31% GlobeNewswire
Feb-23	Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 KYNB -9.57% KYNB GlobeNewswire
Feb-17	Kyntra Bio to Participate in Upcoming Investor Conferences KYNB +6.28% KYNB GlobeNewswire